These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 25785115)

  • 1. Elevated red blood cell distribution width in benign prostatic hyperplasia patients with metabolic syndrome.
    Dong X; Liao Y; Chen K; Fang Y; Li W; Chen J; You L; Li S
    Int J Clin Exp Med; 2015; 8(1):1213-9. PubMed ID: 25785115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between lower urinary tract symptoms/benign prostatic hyperplasia and the number of components of metabolic syndrome.
    Park YW; Kim SB; Kwon H; Kang HC; Cho K; Lee KI; Kim YJ; Lee JH
    Urology; 2013 Sep; 82(3):674-9. PubMed ID: 23850334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Relationship between Benign Prostatic Hyperplasia/Lower Urinary Tract Symptoms and Mean Platelet Volume: The Role of Metabolic Syndrome.
    Zhao S; Tang J; Shao S; Yan Y
    Urol Int; 2016; 96(4):449-58. PubMed ID: 26745140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between benign prostatic hyperplasia, body mass index, and metabolic syndrome in Chinese men.
    Yin Z; Yang JR; Rao JM; Song W; Zhou KQ
    Asian J Androl; 2015; 17(5):826-30. PubMed ID: 25677137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between metabolic syndrome and intravesical prostatic protrusion in patients with benign prostatic enlargement and lower urinary tract symptoms (MIPS Study).
    Russo GI; Regis F; Spatafora P; Frizzi J; Urzì D; Cimino S; Serni S; Carini M; Gacci M; Morgia G
    BJU Int; 2018 May; 121(5):799-804. PubMed ID: 28872764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impacts of metabolic syndrome and lifestyle on the prevalence of benign prostatic hyperplasia requiring treatment: historical cohort study of 130 454 men.
    Yoo S; Oh S; Park J; Cho SY; Cho MC; Jeong H; Son H
    BJU Int; 2019 Jan; 123(1):140-148. PubMed ID: 30125452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association Between Prostate Volume and Red Cell Distribution Width.
    Zorba OÜ; Uzun H; Önem K; Çetinkaya M; Rifaioğlu M; Akça N
    Low Urin Tract Symptoms; 2014 Jan; 6(1):52-6. PubMed ID: 26663501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The single nucleotide polymorphism rs700518 is an independent risk factor for metabolic syndrome and benign prostatic hyperplasia (MetS-BPH).
    Chen ZP; Yan Y; Chen CJ; Li M; Chen C; Zhao SC; Song T; Liu T; Zou CH; Xu Q; Li X
    Andrology; 2018 Jul; 6(4):568-578. PubMed ID: 29873201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic syndrome and lower urinary tract symptoms: the role of inflammation.
    Gacci M; Vignozzi L; Sebastianelli A; Salvi M; Giannessi C; De Nunzio C; Tubaro A; Corona G; Rastrelli G; Santi R; Nesi G; Serni S; Carini M; Maggi M
    Prostate Cancer Prostatic Dis; 2013 Mar; 16(1):101-6. PubMed ID: 23165431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between predictors of the risk of clinical progression of benign prostatic hyperplasia and metabolic syndrome in men with moderate to severe lower urinary tract symptoms.
    Kwon H; Kang HC; Lee JH
    Urology; 2013 Jun; 81(6):1325-9. PubMed ID: 23602796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of lower urinary tract symptom/benign prostatic hyperplasia measures with international index of erectile function 5 in middle-aged policemen of Korea and the role of metabolic syndrome and testosterone in their relationship.
    Lee JH; Kwon H; Park YW
    Urology; 2013 Nov; 82(5):1008-12. PubMed ID: 24041675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Relationship between the Clinical Progression of Benign Prostatic Hyperplasia and Metabolic Syndrome: A Prospective Study.
    Fu Y; Zhou Z; Yang B; Zhang K; He L; Zhang X
    Urol Int; 2016; 97(3):330-335. PubMed ID: 27509202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical, anthropometric, metabolic and insulin profile of men with fast annual growth rates of benign prostatic hyperplasia.
    Hammarsten J; Högstedt B
    Blood Press; 1999; 8(1):29-36. PubMed ID: 10412880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic syndrome and benign prostatic hyperplasia: association or coincidence?
    Rył A; Rotter I; Miazgowski T; Słojewski M; Dołęgowska B; Lubkowska A; Laszczyńska M
    Diabetol Metab Syndr; 2015; 7():94. PubMed ID: 26516352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic syndrome and benign prostatic enlargement: a systematic review and meta-analysis.
    Gacci M; Corona G; Vignozzi L; Salvi M; Serni S; De Nunzio C; Tubaro A; Oelke M; Carini M; Maggi M
    BJU Int; 2015 Jan; 115(1):24-31. PubMed ID: 24602293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association Between Mean Platelet Volume and Benign Prostatic Hyperplasia: A Population Study from the TCLSIH Cohort Study.
    Song Y; Gu Y; Guo H; Yang H; Wang X; Wu H; Wang A; Wang M; Wang H; Zhang Q; Liu L; Meng G; Liu B; Niu K
    J Inflamm Res; 2023; 16():3259-3269. PubMed ID: 37564954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperinsulinaemia as a risk factor for developing benign prostatic hyperplasia.
    Hammarsten J; Högstedt B
    Eur Urol; 2001 Feb; 39(2):151-8. PubMed ID: 11223674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The association between metabolic syndrome and lower urinary tract symptoms suggestive of benign prostatic hyperplasia in aging males: evidence based on propensity score matching.
    Xiong Y; Zhang Y; Tan J; Qin F; Yuan J
    Transl Androl Urol; 2021 Jan; 10(1):384-396. PubMed ID: 33532326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between benign prostatic hyperplasia/lower urinary tract symptoms and total serum testosterone level in healthy middle-aged eugonadal men.
    Lee JH; Kim Y; Park YW; Lee DG
    J Sex Med; 2014 May; 11(5):1309-15. PubMed ID: 24612680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Relationship between Eicosanoid Levels and Serum Levels of Metabolic and Hormonal Parameters Depending on the Presence of Metabolic Syndrome in Patients with Benign Prostatic Hyperplasia.
    Grzesiak K; Rył A; Stachowska E; Słojewski M; Rotter I; Ratajczak W; Sipak O; Piasecka M; Dołęgowska B; Laszczyńska M
    Int J Environ Res Public Health; 2019 Mar; 16(6):. PubMed ID: 30897712
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.